Drugs / Hypertonic lactate
Hypertonic lactate
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 34 trials | ||||||
| Phase 3 | NCT01433276 | Jul 2009 → Jan 2011 | — | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00966628 | May 2008 → Apr 2009 | dengue shock syndrome | Innogene Kalbiotech Pte. Ltd | Unknown | No outcome recorded |
| Phase 3 | NCT00529711 | Jul 2005 → Jul 2006 | cardiogenic shock | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00529490 | Mar 2002 → Jun 2003 | — | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01654653 | Jul 2008 → Mar 2009 | coronary artery disorder | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypertonic lactate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00529711 ↗ |
| Known as | HSL | “Hypertonic Sodium Lactate (HSL) administration during cardiac surgery shows a promising effect.” NCT01654653 ↗ |
| Known as | Hypertonic sodium lactate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00966628 ↗ |
| Known as | Totilac | “A proprietary solution containing hyperosmolar sodium lactate (Totilac) is a hyperosmolar solution with a physiological concentration of potassium chloride and calcium chloride.” NCT01433276 ↗1“followed by Totilac which was given 5 mL/kgBW/15 minutes” NCT01433276 ↗ |
| Route | Other | “Parenteral solution administered to a maximal volume of 10 ml/kg BW over the first 12 hours post-CABG” NCT00529490 ↗ |